SIREN : 328384326
SAPROMAB is a French company founded 42 years ago, specialized in the sector Location de logements. Based in PROVILLE (59267), this company of category PME shows in 2020 a revenue of 131 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Revenue | 131 235 € | 118 445 € | 134 842 € | 183 276 € |
| Net income | 17 632 € | 100 926 € | -106 726 € | 105 074 € |
| EBITDA | -27 735 € | -73 117 € | -46 924 € | -215 354 € |
| Net margin | 13.4% | 85.2% | -79.1% | 57.3% |
In 2020, SAPROMAB achieves revenue of 131 k€. Revenue is declining over the period 2017-2020 (CAGR: -10.5%). Vs 2019, growth of +11% (118 k€ -> 131 k€). After deducting consumption (0 €), gross margin stands at 131 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -28 k€, representing -21.1% of revenue. Positive scissor effect: EBITDA margin improves by +40.6 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 18 k€, i.e. 13.4% of revenue. This profit can be retained or distributed to shareholders.
131 235 €
131 235 €
-27 735 €
-46 855 €
17 632 €
-21.1%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 96%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.892%
96.092%
-21.711%
-0.233
51.0%
In 2020, the debt ratio of SAPROMAB (0.89) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2020, the financial autonomy of SAPROMAB (96.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2020, the repayment capacity of SAPROMAB (-0.23) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 725.18. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
725.176
0.0
In 2020, the liquidity ratio of SAPROMAB (725.18) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2020, the interest coverage of SAPROMAB (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 307 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 8 days. The gap of 299 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 507 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 926 days of revenue, i.e. 338 k€ to permanently finance. Over 2017-2020, WCR increased by +38%, requiring additional financing.
337 536 €
307 j
8 j
507 j
926 j
Based on 193 transactions of similar company sales in 2020, the value of SAPROMAB is estimated at 85 749 € (range 44 244€ - 191 669€). The price/revenue ratio is 0.62x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 193 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SAPROMAB with other companies in the same sector:
Voir toutes les statistiques du secteur Location de logements
The revenue of SAPROMAB in 2020 is 131 k€.
Yes, SAPROMAB generated a net profit of 18 k€ in 2020.
The headquarters of SAPROMAB is located in PROVILLE (59267), in the department Nord.
The tax return of SAPROMAB is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SAPROMAB operates in the sector Location de logements (NAF code 68.20A). See the 'Sector positioning' section above to compare the company with its competitors.